Skip to main content

Yongchang Zhang

Dr Yongchang Zhang is an Associate Professor at Central South University in Changsha, China. His research focuses on lung cancer, with a particular interest in understanding resistance mechanisms for targeted therapies and identifying biomarkers of efficacy and toxicity for immunotherapy.

Dr Zhang is a member of the Cancer Precision Oncology and Oncology Respirology committees of the Chinese Anti-Cancer Association as well as a committee member of the Chinese Society of Clinical Oncology. He is also a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the International Association for the Study of Lung Cancer.

He has published extensively in peer-reviewed journals, including The Lancet Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology, Oncogene, JAMA Network Open, and BMC Medicine, with 50 publications between 2018 and 2021.


Latest contributions from Yongchang Zhang

ALK-ROS Panel discussion teaser

28-03-2022 | Non-small-cell lung cancer | Video

ALK fusion-positive NSCLC: International approaches to management

Ross Camidge leads Rosario García Campelo and Yongchang Zhang in a discussion on the detection and treatment of ALK fusion-positive NSCLC in current practice.